Rejection; Transplant, Liver research hub
3 indexed studies · 1 currently recruiting
- active not recruitingPHASE1, PHASE2
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
This study looks into a new treatment called QEL-001 for people who have had a liver transplant. The aim is to see if QEL-001, made from the patient's own cells, can help prevent the body from rejecting the new liver, especially when usual anti-rejection medicines are reduced or stopped.
Belgium · Spain · United Kingdom - active not recruiting
Epidemiology of Complications After Solid Organ Transplantation - EpCOT Study
This study looks at health problems, especially cancer, after organ transplants in the UK. Researchers are combining existing patient information to better understand why cancer happens and how it affects people after a transplant, to help improve care.
United Kingdom - recruitingPHASE1
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment
This study is looking into a new treatment called sacituzumab govitecan for people with advanced cancer and some liver problems. It aims to find the safest dose and understand its effects in this group of patients.
United States · France · Italy